← brief for 2026-09-13 · Slowing decline

The 2025 AHA/ACC Hypertension Guidelines: Key Updates, Historical Context, and Clinical Implications.

Key takeaways

This review walks through the 2025 US blood pressure guideline from the American Heart Association and the American College of Cardiology. The blood pressure target stays where it was, under 130/80, but the guideline now uses a new risk calculator called PREVENT that leaves race out, and starts blood pressure drugs once 10-year risk reaches 7.5%. Keeping blood pressure down is one of the strongest tools for slowing kidney decline, so the target and the treatment threshold matter here. This is a summary of guidance, not a new study, so there are no new results to report.

Who did this work

Giacona JM (Hypertension Section, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. john.giacona@utsouthwestern.edu.) · Vongpatanasin W (Hypertension Section, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA.)

Source

Paper · Europe PMC, CKD mind-body · 2026-09-07
https://doi.org/10.1007/s11886-026-02413-0